Wall Street Zen Upgrades Koninklijke Philips (NYSE:PHG) to Buy

Koninklijke Philips (NYSE:PHG) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

Other analysts have also issued reports about the company. Sanford C. Bernstein raised Koninklijke Philips to a “hold” rating in a report on Wednesday, December 17th. Royal Bank Of Canada initiated coverage on Koninklijke Philips in a research note on Wednesday, December 17th. They issued a “sector perform” rating for the company. Zacks Research raised shares of Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research report on Friday, March 13th. Finally, Weiss Ratings upgraded shares of Koninklijke Philips from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, March 18th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Koninklijke Philips Stock Down 1.3%

NYSE PHG opened at $26.80 on Friday. The company has a current ratio of 1.32, a quick ratio of 0.94 and a debt-to-equity ratio of 0.63. The company has a market cap of $25.80 billion, a price-to-earnings ratio of 25.28, a PEG ratio of 7.72 and a beta of 0.77. The company has a 50 day moving average of $29.51 and a 200-day moving average of $28.43. Koninklijke Philips has a 1-year low of $21.48 and a 1-year high of $33.44.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings results on Tuesday, February 10th. The technology company reported $0.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.20. The business had revenue of $5.98 billion for the quarter, compared to the consensus estimate of $5.03 billion. Koninklijke Philips had a return on equity of 13.68% and a net margin of 5.09%. On average, equities research analysts expect that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Institutional Trading of Koninklijke Philips

Institutional investors and hedge funds have recently modified their holdings of the business. Royal Bank of Canada boosted its stake in Koninklijke Philips by 1.3% in the first quarter. Royal Bank of Canada now owns 269,829 shares of the technology company’s stock valued at $6,854,000 after buying an additional 3,540 shares in the last quarter. AQR Capital Management LLC grew its position in Koninklijke Philips by 60.8% in the first quarter. AQR Capital Management LLC now owns 17,010 shares of the technology company’s stock valued at $432,000 after acquiring an additional 6,429 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in Koninklijke Philips by 1.5% during the first quarter. Goldman Sachs Group Inc. now owns 846,253 shares of the technology company’s stock worth $21,495,000 after acquiring an additional 12,908 shares in the last quarter. Jane Street Group LLC lifted its holdings in shares of Koninklijke Philips by 125.8% in the first quarter. Jane Street Group LLC now owns 104,024 shares of the technology company’s stock worth $2,642,000 after acquiring an additional 57,952 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Koninklijke Philips by 58.0% in the second quarter. JPMorgan Chase & Co. now owns 87,616 shares of the technology company’s stock worth $2,101,000 after acquiring an additional 32,180 shares during the last quarter. 13.67% of the stock is currently owned by institutional investors.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. (NYSE: PHG), commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips’ principal activities center on medical technologies and personal health.